Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -2264.44%, near the high end of its 5-year range (-41875.18%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-4480.17%
NET PROFIT MARGIN AVG 5Y
-2264.44%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 740 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Adagio Medical Holdings, Inc.
Market Cap
$3.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-4480.17%
5Y Avg
-2264.44%
Market Cap
$3.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.07M
Net Profit Margin
-3089.55%
TTM Avg
-3099.32%
3Y Avg
-6095.20%
5Y Avg
-22555.36%
Market Cap
$3.20M
Net Profit Margin
-427.67%
TTM Avg
-455.53%
3Y Avg
-478.79%
5Y Avg
-375.12%
Market Cap
$2.67M
Net Profit Margin
-2449.04%
TTM Avg
-339.09%
3Y Avg
-222.12%
5Y Avg
-170.97%
Market Cap
$3.25M
Net Profit Margin
-87.20%
TTM Avg
-5303.47%
3Y Avg
-2728.60%
5Y Avg
-1828.05%
Market Cap
$3.28M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-523.72%
5Y Avg
-1138.73%
Market Cap
$2.57M
Net Profit Margin
-123.38%
TTM Avg
-169.81%
3Y Avg
-184.41%
5Y Avg
-199.55%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $3.00M | 0.00% | 0.00% | -4480.17% | -2264.44% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | -3089.55% | -3099.32% | -6095.20% | -22555.36% |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.20M | -427.67% | -455.53% | -478.79% | -375.12% |
| iSpecimen Inc. (ISPC)vs › | $2.67M | -2449.04% | -339.09% | -222.12% | -170.97% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -87.20% | -5303.47% | -2728.60% | -1828.05% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.28M | 0.00% | 0.00% | -523.72% | -1138.73% |
| Nuwellis, Inc. (NUWE)vs › | $2.57M | -123.38% | -169.81% | -184.41% | -199.55% |
| Jaguar Health, Inc. (JAGX)vs › | $2.50M | -131.76% | -396.75% | -403.38% | -531.17% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -41875.18% |
| 2024-09-30 | -2502.16% |
| 2024-06-30 | -2257.48% |
| 2024-03-31 | -30838.46% |
| 2023-12-31 | -11720.51% |
| 2023-09-30 | -26246.34% |
| 2023-06-30 | -6555.37% |
| 2023-03-31 | -15460.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
